BNTXBioNTech SE
- Market cap
- $22.13B
- as of 2026-10-23
- Latest close
- $88.11
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-04-23
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sahin UgurChief Executive Officer | Oct 9 | Oct 9 | S | 36,209 | $95.37 | Sale −$3,453,372 | not reported | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Oct 8 | Oct 9 | S | 27,000 | $92.31 | Sale −$2,492,483 | 36,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Oct 7 | Oct 7 | S | 24,000 | $95.86 | Sale −$2,300,633 | 63,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Oct 6 | Oct 6 | S | 21,000 | $96.81 | Sale −$2,032,995 | 87,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Oct 5 | Oct 6 | S | 72,000 | $97.23 | Sale −$7,000,646 | 108,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Oct 2 | Oct 2 | S | 17,000 | $96.72 | Sale −$1,644,323 | 180,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Oct 1 | Oct 2 | S | 17,000 | $97.46 | Sale −$1,656,745 | 197,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 30 | Sep 30 | S | 32,000 | $98.12 | Sale −$3,139,840 | 214,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 29 | Sep 30 | S | 34,000 | $98.26 | Sale −$3,340,840 | 246,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 28 | Sep 28 | S | 34,000 | $98.47 | Sale −$3,347,980 | 280,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 25 | Sep 28 | S | 27,000 | $98.69 | Sale −$2,664,630 | 314,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 24 | Sep 24 | S | 39,000 | $98.99 | Sale −$3,860,610 | 341,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 23 | Sep 24 | S | 30,000 | $99.40 | Sale −$2,982,000 | 380,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 22 | Sep 22 | S | 46,000 | $100.72 | Sale −$4,633,120 | 410,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 21 | Sep 22 | S | 33,000 | $97.81 | Sale −$3,227,730 | 456,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 18 | Sep 18 | S | 30,000 | $96.22 | Sale −$2,886,600 | 489,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 17 | Sep 18 | S | 34,000 | $98.60 | Sale −$3,352,400 | 519,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 16 | Sep 16 | S | 15,000 | $96.09 | Sale −$1,441,350 | 553,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 15 | Sep 16 | S | 34,000 | $96.49 | Sale −$3,280,660 | 568,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 14 | Sep 14 | S | 41,000 | $99.45 | Sale −$4,077,450 | 602,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 11 | Sep 14 | S | 45,000 | $96.93 | Sale −$4,361,850 | 643,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 10 | Sep 11 | S | 20,500 | $96.31 | Sale −$1,974,355 | 688,209 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 9 | Sep 9 | S | 36,000 | $97.78 | Sale −$3,520,080 | 708,709 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 8 | Sep 9 | S | 37,000 | $99.20 | Sale −$3,670,400 | 744,709 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 4 | Sep 8 | S | 31,500 | $103.52 | Sale −$3,260,880 | 781,709 | Yes | Form 4 |
| Sahin UgurChief Executive Officer | Sep 3 | Sep 8 | S | 45,000 | $102.85 | Sale −$4,628,250 | 813,209 | Yes | Form 4 |
| Poetting SierkChief Operating Officer | May 12 | May 13 | A · derivative | 12,586 | $0.00 | $0 | 12,586 | No | Form 4 |
| Poetting SierkChief Operating Officer | May 12 | May 13 | A · derivative | 10,069 | $0.00 | $0 | 10,069 | No | Form 4 |
| Hanekamp AnnemarieChief Commercial Officer | May 12 | May 13 | A · derivative | 12,586 | $0.00 | $0 | 12,586 | No | Form 4 |
| Hanekamp AnnemarieChief Commercial Officer | May 12 | May 13 | A · derivative | 10,069 | $0.00 | $0 | 10,069 | No | Form 4 |
| Ryan James Timothy PatrickSee remarks. | May 12 | May 13 | A · derivative | 12,586 | $0.00 | $0 | 12,586 | No | Form 4 |
| Ryan James Timothy PatrickSee remarks. | May 12 | May 13 | A · derivative | 10,069 | $0.00 | $0 | 10,069 | No | Form 4 |
| Jimenez KylieChief People Officer | May 12 | May 13 | A · derivative | 10,488 | $0.00 | $0 | 10,488 | No | Form 4 |
| Jimenez KylieChief People Officer | May 12 | May 13 | A · derivative | 8,391 | $0.00 | $0 | 8,391 | No | Form 4 |
| Zapata Gomez RamonChief Financial Officer | May 12 | May 13 | A · derivative | 18,879 | $0.00 | $0 | 18,879 | No | Form 4 |
| Zapata Gomez RamonChief Financial Officer | May 12 | May 13 | A · derivative | 15,103 | $0.00 | $0 | 15,103 | No | Form 4 |
| Poetting SierkChief Operating Officer | Apr 22 | Apr 23 | S | 50,000 | $110.56 | Sale −$5,528,000 | 399,387 | Yes | Form 4 |